Search hospitals > Indiana > Richmond
Reid Health
Claim this profileRichmond, Indiana 47374
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Adenocarcinoma
Conducts research for Non-Small Cell Lung Cancer
394 reported clinical trials
2 medical researchers
Summary
Reid Health is a medical facility located in Richmond, Indiana. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Non-Small Cell Lung Cancer and other specialties. Reid Health is involved with conducting 394 clinical trials across 467 conditions. There are 2 research doctors associated with this hospital, such as Howard M. Gross and Jithendra Choudary, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
Top PIs
Howard M. GrossDayton Physician LLC-Miami Valley Hospital North4 years of reported clinical research
Expert in Cancer
Expert in Breast Cancer
128 reported clinical trials
194 drugs studied
Jithendra Choudary, MDReid Health7 years of reported clinical research
Studies Heart Disease
Studies Myocardial Ischemia
1 reported clinical trial
2 drugs studied
Clinical Trials running at Reid Health
Breast Cancer
Bladder Cancer
Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Prostate Cancer
Bladder Carcinoma
Melanoma
Cutaneous Melanoma
Squamous Cell Carcinoma
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Reid Health?
Reid Health is a medical facility located in Richmond, Indiana. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Non-Small Cell Lung Cancer and other specialties. Reid Health is involved with conducting 394 clinical trials across 467 conditions. There are 2 research doctors associated with this hospital, such as Howard M. Gross and Jithendra Choudary, MD.
Where is Reid Health located?
**Reid Health Hospital Location:**
- Address: 1100 Reid Parkway, Richmond, IN 47374.
- Directions: From downtown Richmond, head north on North 12th Street, turn right onto East Main Street, then turn left onto North 16th Street. Continue onto Chester Boulevard, then turn right onto Reid Parkway.
Who should I call to ask about financial aid or insurance network?
For financial assistance at Reid Health, visit the Patient Financial Services office at 600 East Main, Richmond, or the Patient Advocates at 1100 Reid Parkway. Alternatively, call customer service at (765) 983-3184 or download the Financial Assistance Policy and Application at [www.ReidHealth.org/financial-assistance](http://www.ReidHealth.org/financial-assistance). For insurance inquiries, contact ClaimAid at (765) 983-3310.
What insurance does Reid Health accept?
Reid Health accepts a wide range of insurance plans, including but not limited to Aetna, Anthem, Caresource, Cigna, Humana, and UnitedHealthcare, covering commercial, Medicaid, and Medicare policies. Participation may vary by product and is subject to change. Access to services may require authorization by the primary care physician or the managed care plan.
What awards or recognition has Reid Health received?
**Reid Health, Richmond, Indiana**
- Recognized as one of the nation's "Most Wired Hospitals" for the 10th time, showcasing advanced technology use for connecting care providers and patients.
- Accredited by the Healthcare Facilities Accreditation Program (HFAP) for 15 years, affirming a dedication to quality and patient safety.